Tudor Investment Corp ET AL Acquires New Shares in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX)
Tudor Investment Corp ET AL bought a new position in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Free Report) during the 4th quarter, Holdings Channel reports. The institutional investor bought 33,687 shares of the company’s stock, valued at approximately $127,000. Several other large investors have also recently bought and sold shares of the company. Barclays PLC increased […]
Tudor Investment Corp ET AL bought a new position in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Free Report) during the 4th quarter, Holdings Channel reports. The institutional investor bought 33,687 shares of the company’s stock, valued at approximately $127,000. Several other large investors have also recently bought and sold shares of the company. Barclays PLC increased […]
